Stella Pharma Corporation
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Stella Pharma Corporation made a loss over the last year. Stella Pharma Corporation owes ¥0.40 for every ¥1 it owns. Stella Pharma Corporation made a loss in each of the last two years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
LossStella Pharma Corporation made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
4.60The share price is 4.60 times Stella Pharma Corporation's book value per share, higher than 86% of Healthcare companies in Japan.
Market cap
¥14.8 BThe total market value of all of Stella Pharma Corporation's shares at today's price (share price × number of shares), smaller than 53% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥3.2 BWhat Stella Pharma Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥89.34Net worth divided by the number of shares. The share price of ¥411.00 is 4.6 times this, which is the P/B above.
Return on equity (ROE)
-27.2%Stella Pharma Corporation lost 27.2% of its shareholders' money over the last year, lower than 83% of Healthcare companies in Japan.
Owes vs Owns
0.40×Stella Pharma Corporation owes ¥0.40 for every ¥1 it owns (low), higher than 52% of Healthcare companies in Japan.
Dividend yield
NoneStella Pharma Corporation does not currently pay a dividend.
Revenue growth
-66%Revenue fell 66% in the year to Mar 2026, and grew 12% a year on average over 3 years.
Profit growth
LossStella Pharma Corporation made a loss in each of the last two years.
Profit margin
-241.5%Stella Pharma Corporation lost ¥241 for every ¥100 of revenue.
Interest cover
Not coveredStella Pharma Corporation's operating profit did not cover its interest costs in the year to Mar 2026.
Cash vs debt
Net cashStella Pharma Corporation held ¥2.1 B more cash than debt (net cash) at Mar 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Stella Pharma Corporation: ¥14.8 B ÷ ¥3.2 B (30 Jun 2026) = 4.6.
What is Stella Pharma Corporation's return on equity?
Stella Pharma Corporation lost 27.2% of its shareholders' money over the last year, lower than 83% of Healthcare companies in Japan.
How much does Stella Pharma Corporation owe compared with what it owns?
Stella Pharma Corporation owes ¥0.40 for every ¥1 it owns (low), higher than 52% of Healthcare companies in Japan.
Does Stella Pharma Corporation pay a dividend?
No. Stella Pharma Corporation does not currently pay a dividend.
Is Stella Pharma Corporation's revenue growing?
Revenue fell 66% in the year to Mar 2026, and grew 12% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.